Crossmark

Can levocarnitine supplementation improve fatigue caused by sunitinib as a treatment for renal cell carcinoma? A single-center prospective pilot study

Crossref DOI link: https://doi.org/10.1007/s00520-018-4521-6

Published Online: 2018-10-29

Published Print: 2019-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shindo, Tetsuya https://orcid.org/0000-0002-4990-8330
Kobayashi, Ko

Tanaka, Toshiaki

Masumori, Naoya
License Information

Text and Data Mining valid from 2018-10-29
More Information

Article History

Received: 20 July 2017

Accepted: 26 September 2018

First Online: 29 October 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below